Cargando…

Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy

According to national cancer registry data in Japan, approximately 20,000 adolescents and young adults (AYAs, age 15–39 years) are newly diagnosed with cancer each year. Improvements in treatment and care for AYAs with cancer are included in the Phase Three Basic Plan to Promote Cancer Control Progr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakata, Kayo, Hiyama, Eiso, Katanoda, Kota, Matsuda, Tomohiro, Tada, Yuma, Inoue, Masami, Kawa, Keisei, Maru, Mitsue, Shimizu, Chikako, Horibe, Keizo, Miyashiro, Isao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Invited Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732807/ https://www.ncbi.nlm.nih.gov/pubmed/34779960 http://dx.doi.org/10.1007/s10147-021-02064-x

Ejemplares similares

Trends in survival of leukemia among children, adolescents, and young adults: A population‐based study in Osaka, Japan
por: Nakata, Kayo, et al.
Publicado: (2021)

Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016–2018
por: Nakata, Kayo, et al.
Publicado: (2023)

Incidence of second primary cancers among survivors of childhood cancer: A population‐based study, Osaka, Japan, 1975–2015
por: Odani, Satomi, et al.
Publicado: (2022)

Childhood cancer incidence and survival in Japan and England: A population‐based study (1993‐2010)
por: Nakata, Kayo, et al.
Publicado: (2017)

Childhood, adolescent and young adult cancer incidence in Japan in 2009–2011
por: Katanoda, Kota, et al.
Publicado: (2017)

Geriatric assessment domains to predict overall survival in older cancer patients: An analysis of functional status, comorbidities, and nutritional status as prognostic factors
por: Morishima, Toshitaka, et al.
Publicado: (2020)

Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2050: A Statistical Modeling Study
por: Nguyen, Phuong The, et al.
Publicado: (2023)

Survival in non-small cell lung cancer patients with versus without prior cancer
por: Sato, Akira, et al.
Publicado: (2023)

Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study
por: Sato, Akira, et al.
Publicado: (2021)

Between-hospital variations in 3-year survival among patients with newly diagnosed gastric, colorectal, and lung cancer
por: Morishima, Toshitaka, et al.
Publicado: (2022)

Minimum surgical volume to ensure 5‐year survival probability for six cancer sites in Japan
por: Okawa, Sumiyo, et al.
Publicado: (2022)

Surgical volume threshold to improve 3‐year survival in designated cancer care hospitals in 2004‐2012 in Japan
por: Okawa, Sumiyo, et al.
Publicado: (2022)

Three‐year survival from diagnosis in surgically treated patients in designated and nondesignated cancer care hospitals in Japan
por: Okawa, Sumiyo, et al.
Publicado: (2021)

Increase in incidental detection of thyroid cancer in Osaka, Japan
por: Toyoda, Yasuhiro, et al.
Publicado: (2018)

Prevalence of diabetes in Japanese patients with cancer
por: Saito, Eiko, et al.
Publicado: (2020)

Fluorescence Image-Guided Navigation Surgery Using Indocyanine Green for Hepatoblastoma
por: Hiyama, Eiso
Publicado: (2021)

Trends in lung cancer incidence by gender, histological type and stage at diagnosis in Japan, 1993 to 2015: A multiple imputation approach
por: Nguyen, Phuong The, et al.
Publicado: (2022)

Fifteen‐year survival and conditional survival of women with breast cancer in Osaka, Japan: A population‐based study
por: Kato, Mizuki, et al.
Publicado: (2023)

Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis
por: Odani, Satomi, et al.
Publicado: (2021)

Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data
por: Ito, Yuri, et al.
Publicado: (2014)

Is young‐onset esophageal adenocarcinoma increasing in Japan? An analysis of population‐based cancer registries
por: Saito, Eiko, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on mortality trends in Japan: a reversal in 2021? A descriptive analysis of national mortality data, 1995–2021
por: Tanaka, Hirokazu, et al.
Publicado: (2023)

Patterns of staging, treatment, and mortality in gastric, colorectal, and lung cancer among older adults with and without preexisting dementia: a Japanese multicentre cohort study
por: Morishima, Toshitaka, et al.
Publicado: (2023)

Impact of Comorbidities on Survival in Gastric, Colorectal, and Lung Cancer Patients
por: Morishima, Toshitaka, et al.
Publicado: (2019)

Socioeconomic disparities in cancer survival: Relation to stage at diagnosis, treatment, and centralization of patients to accredited hospitals, 2005–2014, Japan
por: Odani, Satomi, et al.
Publicado: (2022)

Updated Trends in Cancer in Japan: Incidence in 1985–2015 and Mortality in 1958–2018—A Sign of Decrease in Cancer Incidence
por: Katanoda, Kota, et al.
Publicado: (2021)

Barthel Index-based functional status as a prognostic factor in young and middle-aged adults with newly diagnosed gastric, colorectal and lung cancer: a multicentre retrospective cohort study
por: Morishima, Toshitaka, et al.
Publicado: (2021)

Sodium sensing in the brain
por: Noda, Masaharu, et al.
Publicado: (2014)

Toward Better Utilization of the 2015 Japan Standard Population
por: Katanoda, Kota, et al.
Publicado: (2023)

Practical Implications of the Update to the 2015 Japan Standard Population: Mortality Archive From 1950 to 2020 in Japan
por: Tanaka, Hirokazu, et al.
Publicado: (2023)

Impact of coexisting diabetes on survival and risk of developing second primary cancer in diabetes patients receiving drug therapy: A multicenter retrospective cohort study of patients with cancer in Japan
por: Kuwabara, Yoshihiro, et al.
Publicado: (2022)

Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy
por: Fukazawa, Takahiro, et al.
Publicado: (2022)

Trends in non‐Hodgkin lymphoma mortality rate in Japan and the United States: A population‐based study
por: Usui, Yoshiaki, et al.
Publicado: (2023)

Length of Telomeric Repeats in Neuroblastoma: Correlation with Prognosis and Other Biological Characteristics
por: Hiyama, Eiso, et al.
Publicado: (1992)

International comparison of trends in cancer mortality: Japan has fallen behind in screening-related cancers
por: Katanoda, Kota, et al.
Publicado: (2021)

Significant contribution of TRPC6 channel-mediated Ca(2+) influx to the pathogenesis of Crohn's disease fibrotic stenosis
por: Kurahara, Lin Hai, et al.
Publicado: (2016)

What Is the Problem in Clinical Application of Sentinel Node Concept to Gastric Cancer Surgery?
por: Miyashiro, Isao
Publicado: (2012)

Improvement in 5-Year Relative Survival in Cancer of the Corpus Uteri From 1993–2000 to 2001–2006 in Japan
por: Inoue, Shusaku, et al.
Publicado: (2018)

Long-Term Projections of Cancer Incidence and Mortality in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2054: An Empirical Validation Approach
por: Nguyen, Phuong The, et al.
Publicado: (2022)

Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension
por: Hiraishi, Keizo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7n3b48q53gcces29fl8qma8v2p